INS and type 2 diabetes mellitus: To assess the risk of SCD, non-sudden cardiac death and non-fatal cardiac events in patients with probable type 2 diabetes (diabetes patients not treated with insulin), the models presented in Table 3 were re-conducted after exclusion of diabetes patients treated with insulin.